Related Experiment Videos
Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery
1Department of Otorhinolaryngology University of Insubria, Varese, Azienda Ospedaliero Universitaria Ospedale di Circolo e Fondazione Macchi, Varese, Italy. studiodottormacchi@virgilio.it
Insights
Aerosol therapy with thiamphenicol glycinate acetylcysteinate and beclomethasone significantly reduced the need for tonsillectomy and adenoidectomy in children with chronic adenotonsillitis. This treatment also decreased nasal obstruction and infections without adverse events.
Area of Science:
- Pediatric Otolaryngology
- Respiratory Medicine
- Pharmacology
Background:
- Tonsillectomy and adenoidectomy are primary treatments for chronic/recurrent upper respiratory tract infections in children.
- Adenotonsillitis often necessitates surgical intervention due to obstructive symptoms and frequent infections.
Purpose of the Study:
- To evaluate the efficacy of aerosolized thiamphenicol glycinate acetylcysteinate plus beclomethasone in children awaiting tonsillectomy/adenoidectomy.
- To determine if this combination therapy can prevent or postpone necessary surgeries.
Main Methods:
- A randomized controlled trial involving 204 children (1-12 years) with chronic adenotonsillitis.
- Intervention group received aerosolized thiamphenicol glycinate acetylcysteinate (250 mg/day) and beclomethasone (400 µg/day) for 10 days/month over 6 months.
- Control group received no treatment unless required; follow-up at 4, 7, and 12 months.
Main Results:
- Significantly fewer patients in the treatment group required surgery (29% vs. 97% in control, p < 0.0001).
- The therapy led to reduced nasal obstruction and fewer infectious episodes.
- No treatment-related adverse events were reported, and administration was easy for children.
Conclusions:
- Aerosol therapy with thiamphenicol glycinate acetylcysteinate and beclomethasone effectively prevents or postpones surgery for chronic adenotonsillitis in children.
- This approach shows promise as antibiotic prophylaxis for chronic upper airway infections.
Abstract:
Tonsillectomy and adenoidectomy remain the first choice treatment of chronic or recurrent acute infections of the upper respiratory tract in children. The aim of this study is to investigate the efficacy of the combination of thiamphenicol glycinate acetylcysteinate plus beclomethasone, administered as aerosol, in children awaiting tonsillectomy and/or adenoidectomy. The study comprised 204 children, aged 1 to 12 years, with chronic adenotonsillitis who had been listed for surgery due to obstructive symptoms and recurrent acute infections. Patients were randomized to treatment with thiamphenicol glycinate acetylcysteinate, dosage 250 mg/day in 2 administrations plus beclomethasone with a dosage of 400 microg/day in 2 administrations, or no treatment, control group, unless required. The drugs were administered by aerosol for 10 days/month over a period of 6 months. Clinical visits were at 4, 7 and 12 months after the start of treatment. The primary efficacy outcome was the reduction in the number of patients requiring surgery. Secondary efficacy measures were the reduction of nasal obstruction, the decrease in the number of infectious episodes and the tolerability of the treatment. Aerosol treatment with thiamphenicol glycinate acetylcysteinate plus beclomethasone resulted in a significantly lower proportion of patients requiring surgery (29 of 101; 29 percent) compared to patients in the control group (100 of 103; 97 percent) (p < 0.0001). Treatment was also associated with a reduction of nasal obstruction and a decrease in the number of infectious episodes. No treatment-related adverse events were reported and the aerosol therapy proved easy to administer to children. The aerosol therapy with the combination of thiamphenicol glycinate acetylcysteinate plus beclomethasone was able to prevent or postpone surgery in a substantial percentage of patients, without adverse events. These preliminary results suggest that this novel approach could play a role in the antibiotic prophylaxis of chronic infectious diseases of the upper airways.
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhaled Medications
Tonsillitis II: Management
Microbiota of the Respiratory Tract